ArticleWellcome open research2026
Viral hepatitis among vulnerable migrant and refugee populations in Europe - an expert perspective from the Viral Hepatitis Prevention Board.
Article in Wellcome open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Viral hepatitis poses a major individual and public health problem among vulnerable migrant and refugee populations in Europe. Migrants constitute a 'key population' for viral hepatitis elimination, and often face structural and systemic challenges, including limited healthcare access, legal barriers, stigmatization and discrimination. Their vulnerable position, together with documented high prevalence of chronic hepatitis B, C, and D in their countries of origin, place them at particularly high risk of poor health outcomes related to viral hepatitis infection. The Viral Hepatitis Prevention Board (VHPB) convened a multidisciplinary group of experts to discuss barriers to viral hepatitis prevention, diagnosis, and care in migrant populations. This open letter collates outputs from this group, focusing on important barriers and challenges to viral hepatitis prevention, screening and linkage to care for vulnerable migrant populations. It further explores strategies to improve viral hepatitis healthcare for migrants, including equitable access, expanded vaccination and screening, culturally tailored awareness campaigns, community co-production of interventions, and strengthened health systems. It also underlines the importance of sustained policy recommendations, integrating viral hepatitis services into broader health frameworks, promoting international collaboration, and leveraging innovative solutions like digital health records and community-based point-of-care testing or home sampling. Despite commitments to eliminate viral hepatitis by 2030, progress remains slow, with migrants disproportionately affected in the region. Urgent action is needed to close healthcare gaps, address inequities, ensure sustained funding, and implement coordinated efforts to protect vulnerable populations and achieve the elimination goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.